120 related articles for article (PubMed ID: 26430687)
21. Limited use of novel psychoactive substances in South London nightclubs.
Wood DM; Hunter L; Measham F; Dargan PI
QJM; 2012 Oct; 105(10):959-64. PubMed ID: 22718853
[TBL] [Abstract][Full Text] [Related]
22. Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand.
Rychert M; Wilkins C; Parker K; Witten K
Drug Alcohol Rev; 2018 Mar; 37(3):406-413. PubMed ID: 29285812
[TBL] [Abstract][Full Text] [Related]
23. The Effects of Education on Spirituality through Virtual Social Media on the Spiritual Well-Being of the Public Health Students of Isfahan University of Medical Sciences in 2015.
Hasanshahi M; Mazaheri MA
Int J Community Based Nurs Midwifery; 2016 Apr; 4(2):168-75. PubMed ID: 27218114
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the prevalence of medicines and psychoactive substances among drivers in the material of the Department of Forensic Medicine at the Medical University of Bialystok.
Szeremeta M; Ptaszyńska-Sarosiek I; Wardaszka Z; Niemcunowicz-Janica A
Adv Clin Exp Med; 2014; 23(2):245-51. PubMed ID: 24913115
[TBL] [Abstract][Full Text] [Related]
25. Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15.
Hope VD; McVeigh J; Smith J; Glass R; Njoroge J; Tanner C; Parry JV; Ncube F; Desai M
Drug Alcohol Depend; 2017 Oct; 179():83-86. PubMed ID: 28759821
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of psychoactive substances, alcohol and illicit drugs, in Spanish drivers: A roadside study in 2015.
Domingo-Salvany A; Herrero MJ; Fernandez B; Perez J; Del Real P; González-Luque JC; de la Torre R
Forensic Sci Int; 2017 Sep; 278():253-259. PubMed ID: 28778032
[TBL] [Abstract][Full Text] [Related]
27. Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse.
Beck O; Rausberg L; Al-Saffar Y; Villen T; Karlsson L; Hansson T; Helander A
Drug Test Anal; 2014 May; 6(5):492-9. PubMed ID: 24665024
[TBL] [Abstract][Full Text] [Related]
28. Use of psychoactive substances among university students from 2019 to 2020: A systematic review.
Sampaio GR; Lima GS; de Souza SB; Soares DM
Brain Behav Immun Health; 2024 Feb; 35():100724. PubMed ID: 38292320
[TBL] [Abstract][Full Text] [Related]
29. Self-medication among students in Isfahan University of Medical Sciences based on Health Belief Model.
Pirzadeh A; Mostafavi F
J Educ Health Promot; 2014; 3():112. PubMed ID: 25540785
[TBL] [Abstract][Full Text] [Related]
30. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
[TBL] [Abstract][Full Text] [Related]
31. Analysis of legal high materials by ultra-performance liquid chromatography with time of flight mass spectrometry as part of a toxicology vigilance system: what are the most popular novel psychoactive substances in the UK?
Ford LT; Berg JD
Ann Clin Biochem; 2017 Mar; 54(2):219-229. PubMed ID: 27166311
[TBL] [Abstract][Full Text] [Related]
32. [Frequency and risk factors of the use of psychoactive substances among the young].
Pavlović Z; Jakovljević B
Vojnosanit Pregl; 2008 Jun; 65(6):441-8. PubMed ID: 18672700
[TBL] [Abstract][Full Text] [Related]
33. Аnalysis of knowledge of students of higher educational institutions of poltava about the harmfulness of drug use.
Holovanova IA; Smiianov VA; Pluzhnikovа TV; Potseluiev VI; Filatova OV
Wiad Lek; 2018; 71(7):1295-1297. PubMed ID: 30448799
[TBL] [Abstract][Full Text] [Related]
34. Relationship between the components of on-site training and emotional intelligence in the librarians of Isfahan University of Medical Sciences and Isfahan University with moderating role of personality characteristics.
Sayadi S; Safdarian A; Khayeri B
J Educ Health Promot; 2015; 4():89. PubMed ID: 27462631
[TBL] [Abstract][Full Text] [Related]
35. The evaluation of a composed program of continuing medical education for general practitioners.
Moattari M; Yadgari D; Hoseini SJ
J Adv Med Educ Prof; 2014 Jul; 2(3):120-5. PubMed ID: 25512932
[TBL] [Abstract][Full Text] [Related]
36. Patterns and determinants of psychoactive drug use in Lisbon University students--a population-based study.
Cabrita J; Ferreira H; Iglésias P; Baptista T; Rocha E; Lopes da Silva A; Pereira Miguel J
Pharm World Sci; 2004 Apr; 26(2):79-82. PubMed ID: 15085941
[TBL] [Abstract][Full Text] [Related]
37. Psychoactive substances: Position statement on harm reduction.
Stein DJ; Manyedi E
S Afr Med J; 2016 Aug; 106(9):11223. PubMed ID: 27601125
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of a universal internet-based prevention program for ecstasy and new psychoactive substances: a cluster randomized controlled trial.
Champion KE; Newton NC; Stapinski LA; Teesson M
Addiction; 2016 Aug; 111(8):1396-405. PubMed ID: 26880476
[TBL] [Abstract][Full Text] [Related]
39. Effect of information literacy training course on information literacy skills of undergraduate students of Isfahan University of Medical Sciences based on ACRL standards.
Karimi Z; Ashrafi-Rizi H; Papi A; Shahrzadi L; Hassanzadeh A
J Educ Health Promot; 2015; 4():76. PubMed ID: 27462618
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol.
Khaled SM; Hughes E; Bressington D; Zolezzi M; Radwan A; Badnapurkar A; Gray R
Syst Rev; 2016 Nov; 5(1):195. PubMed ID: 27871332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
